![](https://ml.globenewswire.com/media/89f6acc3-0fc3-4af1-84a4-f5b95d218eb8/small/springworks-400x400px-jpg.jpg)
SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors
STAMFORD, Conn., July 29, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the appointment of Martin Mackay, Ph.D. to the …